Swiss biotech BioVersys, which develops treatments for serious infections caused by drug resistant bacteria, has completed its initial public offering with an implied market valuation of 213 million ...

Real-time imaging shows that bacterial resilience to antibiotics is not caused by a few ‘persisters’, but is a ...

Roche, Novartis, Johnson & Johnson Innovative Medicine, Takeda, SHL Medical, Nestlé, Lindt & Sprüngli, Givaudan, Schneider Electric, Schindler, Endress+Hauser Flowtec, VAT Group and SFS Group. They ...

The rise of inspiring deep tech entrepreneurs and the ecosystems around them is one of the most fascinating business ...

UBS analyst Matthew Weston maintained a Buy rating on Novartis AG (NOVN – Research Report) today and set a price target of CHF111.00.Maximize ...

The pharma major beat analysts’ expectations in the fourth quarter of 2024, despite looming competition for its top heart ...

TD Cowen analyst Steve Scala reiterated a Hold rating on Novartis (NVS – Research Report) today and set a price target of $125.00. The ...

Novartis AG released its Annual Report for 2024, alongside its ‘Novartis in Society – Integrated Report 2024.’ This announcement underscores the company ...

BASEL, Switzerland (AP) — BASEL, Switzerland (AP) — Novartis AG (NVS) on Friday reported fourth-quarter net income of $2.82 billion. On a per-share basis, the Basel, Switzerland-based company said it ...

Swiss pharmaceutical giant Novartis on Friday reported fourth-quarter results after repeatedly raising its full-year guidance.

Greece on Monday prosecuted a pair of protected witnesses in a long-running bribery probe involving Swiss pharmaceutical firm Novartis for alleged perjury, a justice source said. The man and woman ...

Mentioning that the pharma industry in Switzerland was worth over $100 billion, Mr. Lokesh sought the cooperation of the envoy in setting up of units by pharma giants like Novartis, Roche ...